Randomized trial demonstrates scalable gene circuits in human cells, indicating solutions for biomedicine and biotechnology.
Engineering mammalian cells to execute complex genetic programs remains a significant challenge in synthetic biology. Synthetic gene circuits typically implement sophisticated programs through cascaded computational layers. However, these architectures require numerous orthogonal parts, increase genetic payload, and deplete cellular resources, thereby limiting functionality and scalability. We present a modular design framework for engineering scalable gene circuits that execute complex functions within fewer computational layers. The platform integrates orthogonal trans-splicing-based AND gates, native-synthetic hybrid promoters for tunable regulation, and synthetic microRNAs that implement inhibitory logic. Using this approach, we engineer complex circuits, including a three-input combinatorial logic gate, a half adder, a full adder, and a dynamic 3-to-1 multiplexer with a dedicated Selector Overload Status output, generated only when both selector inputs are activated. By minimizing the number of computational layers while maintaining functionality, this strategy addresses scalability barriers in gene circuit engineering and expands applicability for biomedicine, biotechnology, and fundamental biology. Synthetic gene circuits enable cellular programming, but executing complex functions in mammalian cells remains challenging. Here, the authors introduce RNA-based circuit designs that enable logic gates, adders, and a multiplexer in fewer computational layers, addressing scalability barriers.
No takes yet. Share an insight, caveat, or question.
Roas et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: